Search

Your search keyword '"Avci B"' showing total 203 results
Start Over Author "Avci B"
203 results on '"Avci B"'

16. Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer

Author

Kiriukova M, de la Iglesia Garcia D, Panic N, Bozhychko M, Avci B, Maisonneuve P, de-Madaria E, Capurso G, and Vasile Sandru

Subjects
nutritional status, dose-intensity, locally advanced, pancreatic cancer, chemotherapy, exocrine pancreatic insufficiency, metastatic
Abstract

Background:Malnutrition and cachexia are common in patients with advanced pancreatic ductal adenocarcinoma (PDAC) and have a significant influence on the tolerance and response to treatments. If timely identified, malnourished PDAC patients could be treated to increase their capacity to complete the planned treatments and, therefore, possibly, improve their efficacy. Aims:The aim of this study is to assess the impact of nutritional status, pancreatic exocrine insufficiency (PEI), and other clinical factors on patient outcomes in patients with advanced PDAC. Methods:PAncreatic Cancer MAlnutrition and Pancreatic Exocrine INsufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer (PAC-MAIN) is an international multicenter prospective observational cohort study. The nutritional status will be determined by means of Mini-Nutritional Assessment score and laboratory blood tests. PEI will be defined by reduced fecal elastase levels. Main outcome: adherence to planned chemotherapy in the first 12 weeks following the diagnosis, according to patients' baseline nutritional status and quantified and reported as "percent of standard chemotherapy dose delivered." Secondary outcomes: rate of chemotherapy-related toxicity, progression-free survival, survival at 6 months, overall survival, quality of life, and the number of hospitalizations. Analysis: chemotherapy dosing over the first 12 weeks of therapy (i.e., percent of chemotherapy received in the first 12 weeks, as defined above) will be compared between well-nourished and malnourished patients. Sample size: based on an expected percentage of chemotherapy delivered of 70% in well-nourished patients, with a type I error of 0.05 and a type II error of 0.20, a sample size of 93 patients per group will be required in case of a percentage difference of chemotherapy delivered of 20% between well-nourished and malnourished patients, 163 patients per group in case of a difference of 15% between the groups, and 356 patients per group in case of a 10% difference. Centers from Russia, Romania, Turkey, Spain, Serbia, and Italy will participate in the study upon Local Ethics Committee approval. Discussion:PAC-MAIN will provide insights into the role of malnutrition and PEI in the outcomes of PDAC. The study protocol was registered atas NCT04112836.

Published
2020

17. Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis

Author

de la Iglesia D, Avci B, Kiriukova M, Panic N, Bozhychko M, Sandru V, de-Madaria E, and Capurso G

Subjects
prevalence, Pancreatic cancer, malnutrition, survival, exocrine pancreatic insufficiency
Abstract

Background Pancreatic cancer is the fourth leading cause of cancer mortality. Most patients are diagnosed with advanced pancreatic cancer, either at locally advanced or metastatic stages, and have a high rate of malnutrition and weight loss which are associated with poor outcomes. Pancreatic exocrine insufficiency is one of the causes of malnutrition and weight loss in these patients. The prevalence and clinical consequences of pancreatic exocrine insufficiency in advanced pancreatic cancer are poorly investigated with heterogeneous results. We sought to determine the prevalence and clinical consequences of pancreatic exocrine insufficiency and the effect of pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer by systematic review and meta-analysis. Methods Scopus, Medline, and Embase were searched for cohort studies or randomised clinical trials reporting pancreatic exocrine insufficiency and/or the effect of pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer. We considered pancreatic exocrine insufficiency as an abnormal result on direct and/or indirect pancreatic exocrine function tests. Pancreatic enzyme replacement therapy was evaluated by its effect on survival and quality of life in patients with advanced pancreatic cancer. Results A total of 11 studies were included; seven studies reported the prevalence of pancreatic exocrine insufficiency and seven the effect of pancreatic enzyme replacement therapy in advanced pancreatic cancer. The pooled prevalence of pancreatic exocrine insufficiency in advanced pancreatic cancer was 72% (95% confidence interval: 55-86%), being significantly higher when tumours were located in the pancreatic head (relative risk = 3.36, 1.07-10.54;p = 0.04) six studies investigated the impact of pancreatic enzyme replacement therapy on survival/quality of life. Pancreatic enzyme replacement therapy was associated with 3.8 months (95% confidence interval: 1.37-6.19) survival benefit. Patients receiving pancreatic enzyme replacement therapy had a trend towards a better quality of life. ConclusionsThe prevalence of pancreatic exocrine insufficiency in advanced pancreatic cancer is substantial and its treatment can improve the outcomes of these patients.

Published
2020

28. The role of P2X7 receptors in penicillin-induced epileptiform activity

Author

Gokhan Arslan, Kocacan, S. E., Ayyildiz, M., Rzayev, E., Avci, B., Agar, E., Ondokuz Mayıs Üniversitesi, [Arslan, G.] Cumhuriyet Univ, Sch Med, Physiol, Sivas, Turkey -- [Kocacan, S. E. -- Ayyildiz, M. -- Agar, E.] Univ Ondokuz Mayis, Sch Med, Physiol, Samsun, Turkey -- [Rzayev, E. -- Avci, B.] Univ Ondokuz Mayis, Sch Med, Biochem, Samsun, Turkey, AVCI, Bahattin -- 0000-0001-6471-6495, and Arslan, Gokhan -- 0000-0003-4186-2478

Abstract

WOS: 000408842000269, …, TUBITAK [115S361], This study supported by TUBITAK (project number: 115S361)

Published
2017

29. Protective effects of curcumin supplementation on oxidant/antioxidant system changes created by organic phosphorus pesticide poisoning

Author

Avci, B., Bilge, S. S., Gokhan Arslan, Alici, O., Darakci, O., Ciftcioglu, E., Baratzada, T., Yardan, T., Bozkurt, A., [Avci, B. -- Baratzada, T.] Ondokuz Mayis Univ, Fac Med, Dept Med Biochem, Samsun, Turkey -- [Bilge, S. S.] Ondokuz Mayis Univ, Fac Med, Dept Pharmacol, Samsun, Turkey -- [Arslan, G.] Cumhuriyet Univ, Fac Med, Dept Physiol, Sivas, Turkey -- [Alici, O.] Gaziosmanpasa Univ, Fac Med, Dept Pathol, Tokat, Turkey -- [Darakci, O. -- Bozkurt, A.] Ondokuz Mayis Univ, Fac Med, Dept Physiol, Samsun, Turkey -- [Ciftcioglu, E.] Ondokuz Mayis Univ, Fac Med, Dept Anat, Samsun, Turkey -- [Yardan, T.] Ondokuz Mayis Univ, Fac Med, Dept Emergency Med, Samsun, Turkey, Bozkurt, Ayhan -- 0000-0002-5794-709X, Ciftcioglu, Engin -- 0000-0003-4402-3004, AVCI, Bahattin -- 0000-0001-6471-6495, and Arslan, Gokhan -- 0000-0003-4186-2478

Abstract

41st FEBS Congress on Molecular and Systems Biology for a Better Life -- SEP 03-08, 2016 -- Kusadasi, TURKEY, WOS: 000383616901852, …, FEBS

Published
2016

30. Genomic and physiological analyses of Reinekea forsetii reveal a versatile opportunistic lifestyle during spring algae

Author

Avci, B., Hahnke, R., Chafee, M., Fischer, T., Gruber-Vodicka, H., Tegetmeyer, Halina E, Harder, J., Fuchs, B.M., Amann, R.I., and Teeling, H.

Subjects
fungi
Abstract

Gammaproteobacterial Reinekea spp. were detected during North Sea spring algae blooms in the years 2009-2012, with relative abundances of up to 16% in the bacterioplankton. Here, we explore the ecophysiology of ‘R. forsetii' strain Hel1_31_D35 that was isolated during the 2010 spring bloom using (i) its manually annotated, high-quality closed genome, (ii) re-analysis of in situ data from the 2009–2012 blooms and (iii) physiological tests. High resolution analysis of 16S rRNA gene sequences suggested that ‘R. forsetii' dominated Reinekea populations during these blooms. This was corroborated by retrieval of almost complete Hel1_31_D35 genomes from 2009 and 2010 bacterioplankton metagenomes. Strain Hel1_31_D35 can use numerous low-molecular weight substrates including diverse sugar monomers, and few but relevant algal polysaccharides such as mannan, α-glucans, and likely bacterial peptidoglycan. It oxidizes thiosulfate to sulfate, and ferments under anoxic conditions. The strain can attach to algae and thrives at low phosphate concentrations as they occur during blooms. Its genome encodes RTX toxin and secretion proteins, and in cultivation experiments Hel1_31_D35 crude cell extracts inhibited growth of a North Sea Polaribacter strain. Our data suggest that the combination of these traits make strain Hel1_31_D35 a versatile opportunist that is particularly competitive during spring phytoplankton blooms.

Published
2017

31. Can we trust the positivity of semi-quantitative glucose measurement in the urine?

Author

Nar R., Avci B., Ondokuz Mayıs Üniversitesi, and Kırşehir Ahi Evran Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri, Tıbbi Biyokimya ABD

Subjects
Glucose, HbA1c, Fasting serum glucose
Abstract

As known, when the blood glucose level exceeds the renal threshold value of 180-200 mg/dL it begins to be excreted with urine. Spot urine analysis is easy to perform and an important test, with false positive or negative test results incompatible with the clinic. Our aim in this study is to investigate the relationship between glucose levels in different sample types with simultaneous measurements.Material and Simultaneous fasting serum glucose, HbA1c levels and urine glucose of 2375 patients were screened retrospectively from the hospital information system between June 1, 2015 and November 30, 2015. Fasting serum glucose was measured by enzymatic hexokinase method in biochemical autoanalyzer, HbA1c was measured by chromatographic method on HPLC and urine glucose was measured semi-quantitatively by urine autoanalyzer by strip glucose oxidase method. It was found that there was a medium-strong relationship between all three results. There was significant; correlation;between; fasting serum glucose and HbA1c (r: 0.787, p < 0.001) and the correlation between urinary glucose and fasting serum glucose and HbA1c were (r: 635, p < 0.001) and (r: 533, p < 0.001), respectively. In our study, we indicated that there is a strong correlation between the glucose results of different types of samples that we use in our laboratory. The patient's concurrently measured HbA1c and fasting serum glucose results may be helpful to the laboratory specialist to avoid both false positives and false negatives. © 2017 OMU.

Published
2017

32. Impact of the seventh day nucleated red blood cell count on mortality in COVID-19 intensive care unit patients: A retrospective case-control study

Author

Düz Muhammed Emin, Arslan Mustafa, Menek Elif E., and Avci Burak Yasin

Subjects
nucleated erythrocytes, covid-19, covid19 pandemic, mortality, survival, Biochemistry, QD415-436
Abstract

Background: COVID-19 covers a broad clinical spectrum, threatening global health. Although several studies have investigated various prognostic biochemical and hematological parameters, they generally lack specificity and are insufficient for decision-making. Beyond the neonatal period, NRBCs (nucleated red blood cells) in peripheral blood is rare and often associated with malignant neoplasms, bone marrow diseases, and other severe disorders such as sepsis and hypoxia. Therefore, we investigated if NRBCs can predict mortality in hypoxic ICU (Intensive Care Unit) patients of COVID-19. Methods: Seventy-one unvaccinated RT-PCR confirmed COVID-19 ICU patients was divided into those who survived (n=35, mean age=58) and died (n=36, mean age=75). Venous blood samples were collected in K3 EDTA tubes and analyzed on a Sysmex XN-1000 hematology analyzer with semiconductor laser flow cytometry and nucleic acid fluorescence staining method for NRBC analysis. NRBC numbers and percentages of the patients were compared on the first and seventh days of admission to the ICU. Results are reported as a proportion of NRBCs per 100 WBCs NRBCs/100 WBC (NRBC% and as absolute NRBC count (NRBC #, × 109/L). Results: NRBC 7th-day count and % values were statistically higher in non-survival ones. The sensitivity for 7th day NRBC value 0.01) significantly predicts mortality in ICU hospitalized patients due to COVID-19. Worse, a high mortality rate is expected, especially with NRBC values of >0.03.

Published
2023
Full Text
View/download PDF

35. Results of using Luer-Lok access device for clinics, intensive care units, and emergency services with high pre-analytical errors: analysis of 491.850 samples

Author

Menekse Elif, Duz Muhammed Emin, Avci Burak Yasin, Ozturk Alpaslan, and Durmaz Mustafa

Subjects
clot, extra-analytical phase, hemolysis, luer-lok, pre-analytical phase, sample rejection, Medical technology, R855-855.5
Abstract

The effectiveness of the Luer-Lok™ Access Device (LL) with the intravenous catheter (IVC) on sample rejections, which is used to prevent primarily hemolysis in the emergency department (ED), clinics, and intensive care units (ICU), was examined.

Published
2022
Full Text
View/download PDF

36. The relationship between plasminogen activator inhibitor-1 levels and the course of disease in COVID-19 patients

Author

Baltan Ecem, Serin Erdinç, Avci Burak Yasin, Akilli Işil Kibar, and Çinar Ayşe Sürhan

Subjects
biochemical, covid-19, fibrinolysis, mortality, pai-1, Biochemistry, QD415-436
Abstract

Studies have shown that fibrinolysis activity is insufficient in COVID-19 patients. Plasminogen activator inhibitor-1 (PAI-1) is an important antifibrinolytic molecule that plays a key role in the fibrinolytic system. In our study; we aimed to evaluate serum PAI-1 and other biochemical parameters of COVID-19 patients in terms of disease course and mortality.

Published
2022
Full Text
View/download PDF

50. Poster session Thursday 6 December - AM: Other myocardial diseases

Author

Ojaghi-Haghighi, Z., primary, Mostafavi, A., additional, Moladoust, H., additional, Noohi, F., additional, Maleki, M., additional, Esmaeilzadeh, M., additional, Samiei, N., additional, Hosseini, S., additional, Jasaityte, R., additional, Teske, A., additional, Claus, P., additional, Verheyden, B., additional, Rademakers, F., additional, D'hooge, J., additional, Patrianakos, A., additional, Zacharaki, A., additional, Kalogerakis, A., additional, Nyktari, E., additional, Maniatakis, P., additional, Parthenakis, F., additional, Vardas, P., additional, Hilde, J. M., additional, Skjoerten, I., additional, Humerfelt, S., additional, Hansteen, V., additional, Melsom, M., additional, Hisdal, J., additional, Steine, K., additional, Ippolito, R., additional, Gripari, P., additional, Muraru, D., additional, Esposito, R., additional, Kocabay, G., additional, Tamborini, G., additional, Galderisi, M., additional, Maffessanti, F., additional, Badano, L., additional, Pepi, M., additional, Yurdakul, S., additional, Oner, F., additional, Sahin, T., additional, Avci, B., additional, Tayyareci, Y., additional, Direskeneli, H., additional, Aytekin, S., additional, Filali, T., additional, Jedaida, B., additional, Lahidheb, D., additional, Gommidh, M., additional, Mahfoudhi, H., additional, Hajlaoui, N., additional, Dahmani, R., additional, Fehri, W., additional, Haouala, H., additional, Andova, V., additional, Georgievska-Ismail, L., additional, Srbinovska-Kostovska, E., additional, Gardinger, Y., additional, Joanna Hlebowicz, J., additional, Ola Bjorgell, O., additional, Magnus Dencker, M., additional, Liao, M.-T., additional, Tsai, C.-T., additional, Lin, J.-L., additional, Piestrzeniewicz, K., additional, Luczak, K., additional, Maciejewski, M., additional, Komorowski, J., additional, Jankiewicz-Wika, J., additional, Drozdz, J., additional, Ismail, M. F., additional, Alasfar, A., additional, Elassal, M., additional, El-Sayed, S., additional, Ibraheim, M., additional, Dobrowolski, P., additional, Klisiewicz, A., additional, Florczak, E., additional, Prejbisz, A., additional, Szwench, E., additional, Rybicka, J., additional, Januszewicz, A., additional, Hoffman, P., additional, Santos Furtado, M., additional, Nogueira, K., additional, Arruda, A., additional, Rodrigues, A. C., additional, Carvalho, F., additional, Silva, M., additional, Cardoso, A., additional, Lira-Filho, E., additional, Pinheiro, J., additional, Andrade, J. L., additional, Mohammed, M., additional, Zito, C., additional, Cusma-Piccione, M., additional, Di Bella, G., additional, Taha, N., additional, Zagari, D., additional, Oteri, A., additional, Quattrone, A., additional, Boretti, I., additional, Carerj, S., additional, Obremska, O., additional, Boratynska, B., additional, Poczatek, P., additional, Zon, Z., additional, Magott, M., additional, Klinger, K., additional, Szenczi, O., additional, Szelid, Z., additional, Soos, P., additional, Bagyura, Z., additional, Edes, E., additional, Jozan, P., additional, Merkely, B., additional, Ahn, J., additional, Kim, D., additional, Jeon, D., additional, Kim, I., additional, Baeza Garzon, F., additional, Delgado, M., additional, Mesa, D., additional, Ruiz, M., additional, De Lezo, J. S., additional, Pan, M., additional, Leon, C., additional, Castillo, F., additional, Morenate, M., additional, Toledano, F., additional, Zhong, L., additional, Lim, E., additional, Shanmugam, N., additional, Law, S., additional, Ong, B., additional, Katwadi, K., additional, Tan, R., additional, Chua, Y., additional, Liew, R., additional, Ding, Z., additional, Von Bibra, H., additional, Leclerque, C., additional, Schuster, T., additional, Schumm-Draeger, P.-M., additional, Bonios, M., additional, Kaladaridou, A., additional, Papadopoulou, O., additional, Tasoulis, A., additional, Pamboucas, C., additional, Ntalianis, A., additional, Nanas, J., additional, Toumanidis, S., additional, Silva, D., additional, Cortez-Dias, N., additional, Carrilho-Ferreira, P., additional, Placido, R., additional, Jorge, C., additional, Calisto, C., additional, Robalo Martins, S., additional, Carvalho De Sousa, J., additional, Pinto, F., additional, Nunes Diogo, A., additional, Przewlocka-Kosmala, M., additional, Orda, A., additional, Karolko, B., additional, Mysiak, A., additional, Kosmala, W., additional, Moral Torres, S., additional, Rodriguez-Palomares, J., additional, Pineda, V., additional, Gruosso, D., additional, Evangelista, A., additional, Garcia-Dorado, D., additional, Figueras, J., additional, Cambronero, E., additional, Corbi, M. J., additional, Valle, A., additional, Cordoba, J., additional, Llanos, C., additional, Fernandez, M., additional, Lopez, I., additional, Hidalgo, V., additional, Barambio, M., additional, Jimenez, J., additional, D'andrea, A., additional, Riegler, L., additional, Cocchia, R., additional, Russo, M., additional, Bossone, E., additional, Calabro, R., additional, Iniesta Manjavacas, A., additional, Valbuena Lopez, S., additional, Lopez Fernandez, T., additional, Garcia-Blas, S., additional, De Torres Alba, F., additional, De Diego, J. G., additional, Ramirez Valdiris, U., additional, Mesa Garcia, J., additional, Moreno Yanguela, M., additional, Lopez-Sendon, J., additional, Logstrup, B., additional, Andersen, H., additional, Thuesen, L., additional, Christiansen, E., additional, Terp, K., additional, Klaaborg, K., additional, Poulsen, S., additional, Cacicedo, A., additional, Velasco, S., additional, Aguirre, U., additional, Onaindia, J., additional, Rodriguez, I., additional, Oria, G., additional, Subinas, A., additional, Zugazabeitia, G., additional, Romero, A., additional, Laraudogoitia Zaldumbide, E., additional, Weisz, S., additional, Magne, J., additional, Dulgheru, R., additional, Rosca, M., additional, Pierard, L., additional, Lancellotti, P., additional, Auffret, V., additional, Donal, E., additional, Bedossa, M., additional, Boulmier, D., additional, Laurent, M., additional, Verhoye, J., additional, Le Breton, H., additional, Van Hall, S., additional, Herbrand, T., additional, Ketterer, U., additional, Keymel, S., additional, Boering, Y., additional, Rassaf, T., additional, Meyer, C., additional, Zeus, T., additional, Kelm, M., additional, Balzer, J., additional, Floria, M., additional, Seldrum, S., additional, Mariciuc, M., additional, Laurence, G., additional, Buche, M., additional, Eucher, P., additional, Louagie, Y., additional, Jamart, J., additional, Marchandise, B., additional, Schroeder, E., additional, Venkatesh, A., additional, Sahlen, A., additional, Johnson, J., additional, Brodin, L., additional, Winter, R., additional, Shahgaldi, K., additional, Manouras, A., additional, Fusini, L., additional, Muratori, M., additional, Alamanni, F., additional, Bartorelli, A., additional, Ferrari, C., additional, Caiani, E., additional, Yaroslavskaya, E., additional, Kuznetsov, V., additional, Pushkarev, G., additional, Krinochkin, D., additional, Zyrianov, I., additional, Ciobotaru, C., additional, Kobayashi, Y., additional, Yamamoto, K., additional, Hirose, E., additional, Hirohata, A., additional, Ohe, T., additional, Jhund, P., additional, Cunningham, T., additional, Murday, V., additional, Findlay, I., additional, Sonecki, P., additional, Rangel, I., additional, Sousa, C., additional, Goncalves, A., additional, Correia, A., additional, Vigario, A., additional, Martins, E., additional, Silva-Cardoso, J., additional, Macedo, F., additional, Maciel, M., additional, Lovric, D., additional, Samardzic, J., additional, Milicic, D., additional, Reskovic, V., additional, Baricevic, Z., additional, Ivanac, I., additional, Separovic Hanzevacki, J., additional, Kim, K., additional, Song, J., additional, Jeong, H., additional, Yoon, H., additional, Ahn, Y., additional, Jeong, M., additional, Cho, J., additional, Park, J., additional, Kang, J., additional, Iorio, A., additional, Pinamonti, B., additional, Bobbo, M., additional, Merlo, M., additional, Barbati, G., additional, Massa, L., additional, Faganello, G., additional, Di Lenarda, A., additional, Sinagra, G., additional, Heggemann, F., additional, Hamm, K., additional, Streitner, F., additional, Sueselbeck, T., additional, Papavassiliu, T., additional, Borggrefe, M., additional, Haghi, D., additional, Ferreira, F., additional, Galrinho, A., additional, Soares, R., additional, Branco, L., additional, Abreu, J., additional, Feliciano, J., additional, Papoila, A., additional, Alves, M., additional, Leal, A., additional, Ferreira, R., additional, Reynaud, A., additional, Lund, L. H., additional, Oger, E., additional, Drouet, E., additional, Hage, C., additional, Bauer, F., additional, Linde, C., additional, Daubert, J., additional, Schnell, F., additional, Lentz, P., additional, Kervio, G., additional, Leurent, G., additional, Mabo, P., additional, Carre, F., additional, Rodrigues, A., additional, Roque, M., additional, Becker, D., additional, Barros, S., additional, Kay, F., additional, Emerick, T., additional, Sampaio-Barros, P., additional, Andrade, J., additional, Yamada, S., additional, Okada, K., additional, Iwano, H., additional, Nishino, H., additional, Nakabachi, M., additional, Yokoyama, S., additional, Kaga, S., additional, Mikami, T., additional, Tsutsui, H., additional, Mincu, R., additional, Magda, S., additional, Dumitrache Rujinski, S., additional, Constantinescu, T., additional, Mihaila, S., additional, Ciobanu, A., additional, Florescu, M., additional, Vinereanu, D., additional, Ashcheulova, T., additional, Kovalyova, O., additional, Ardeleanu, E., additional, Gurgus, D., additional, Gruici, A., additional, Suciu, R., additional, Ana, I., additional, Bergenzaun, L., additional, Ohlin, H., additional, Gudmundsson, P., additional, Willenheimer, R., additional, Chew, M., additional, Charalampopoulos, A., additional, Howard, L., additional, Davies, R., additional, Gin-Sing, W., additional, Tzoulaki, I., additional, Grapsa, I., additional, Gibbs, S., additional, Massabuau, P., additional, Weinert, L., additional, Lairez, O., additional, Berry, M., additional, Sotaquira, M., additional, Vaida, P., additional, Lang, R., additional, Khan, I., additional, Waterhouse, D., additional, Asegdom, S., additional, Alqaseer, M., additional, Foley, D., additional, Mcadam, B., additional, Colonna, P., additional, Michelotto, E., additional, Genco, W., additional, Rubino, M., additional, Pugliese, S., additional, Belfiore, A., additional, Sorino, M., additional, Trisorio Liuzzi, M., additional, Antonelli, G., additional, Palasciano, G., additional, Duszanska, A., additional, Skoczylas, I., additional, Streb, W., additional, Kukulski, T., additional, Polonski, L., additional, Kalarus, Z., additional, Fleig, A., additional, Seitz, K., additional, Secades, S., additional, Martin, M., additional, Corros, C., additional, Rodriguez, M., additional, De La Hera, J., additional, Garcia, A., additional, Velasco, E., additional, Fernandez, E., additional, Barriales, V., additional, Lambert, J., additional, Zwas, D. R., additional, Hoss, S., additional, Leibowitz, D., additional, Beeri, R., additional, Lotan, C., additional, Gilon, D., additional, Wierzbowska-Drabik, K., additional, Roszczyk, N., additional, Sobczak, M., additional, Plewka, M., additional, Chrzanowski, L., additional, Lipiec, P., additional, Kasprzak, J., additional, Wita, K., additional, Mizia-Stec, K., additional, Wrobel, W., additional, Plonska-Gosciniak, E., additional, Pinho, T., additional, Wang, Y., additional, Houle, H., additional, Madureira, A. J., additional, Zamorano, J., additional, Maciel, M. J., additional, Ancona, R., additional, Comenale Pinto, S., additional, Caso, P., additional, Coppola, M., additional, Rapisarda, O., additional, Calabro', R., additional, Cadenas Chamorro, R., additional, Lopez, T., additional, Gomez, J., additional, Moreno, M., additional, Salinas, P., additional, Jimenez Rubio, C., additional, Valbuena, S., additional, Manjavacas, A., additional, De Torres, F., additional, Vaugrenard, T., additional, Huttin, O., additional, Rouge, A., additional, Schwartz, J., additional, Zinzius, P., additional, Popovic, B., additional, Sellal, J., additional, Aliot, E., additional, Juilliere, Y., additional, Selton-Suty, C., additional, Looi, J., additional, Lee, A., additional, Hsiung, M., additional, Song, W., additional, Wong, R., additional, Underwood, M. J., additional, Fang, F., additional, Lin, Q., additional, Lam, Y., additional, Yu, C., additional, Vitarelli, A., additional, Nguyen, B., additional, Capotosto, L., additional, D-Alessandro, G., additional, D-Ascanio, M., additional, Rafique, A., additional, Gang, E., additional, Barilla, F., additional, Siegel, R., additional, Kydd, A., additional, Khan, F., additional, Watson, W., additional, Mccormick, L., additional, Virdee, M., additional, Dutka, D., additional, Ranjbar, S., additional, Karvandi, M., additional, Hassantash, S., additional, Grapsa, J., additional, Efthimiadis, I., additional, Pakrashi, T., additional, Dawson, D., additional, Punjabi, P., additional, Nihoyannopoulos, P., additional, Henein, M., additional, Soderberg, S., additional, Tossavainen, E., additional, Lindqvist, P., additional, Bellsham-Revell, H., additional, Bell, A., additional, Miller, O., additional, Simpson, J., additional, Altekin, E., additional, Kucuk, M., additional, Yanikoglu, A., additional, Karakas, S., additional, Er, A., additional, Ozel, D., additional, Ermis, C., additional, Demir, I., additional, Bajraktari, G., additional, Di Salvo, G., additional, Baldini, L., additional, Del Gaizo, F., additional, Rea, A., additional, Pergola, V., additional, Pacileo, G., additional, Fadel, B., additional, Seo, J.-S., additional, Choi, G.-N., additional, Jin, H.-Y., additional, Seol, S.-H., additional, Jang, J.-S., additional, Yang, T.-H., additional, Kim, D.-K., additional, Kim, D.-S., additional, Papadopoulou, E., additional, Hatzidou, S., additional, Agrios, J., additional, Pamboukas, C., additional, Antoniou, A., additional, Gargiulo, P., additional, Dellegrottaglie, S., additional, Bruzzese, D., additional, Scala, O., additional, D'amore, C., additional, Ruggiero, D., additional, Marciano, C., additional, Vassallo, E., additional, Pirozzi, E., additional, Perrone Filardi, P., additional, Mor-Avi, V., additional, Kachenoura, N., additional, Lodato, J., additional, Port, S., additional, Chandra, S., additional, Freed, B., additional, Bhave, N., additional, Newby, B., additional, Patel, A., additional, Dwivedi, G., additional, Alam, M., additional, Boczar, K., additional, Chow, B., additional, Staskiewicz, G., additional, Czekajska-Chehab, E., additional, Uhlig, S., additional, Tomaszewski, A., additional, Przegalinski, J., additional, Maciejewski, R., additional, Drop, A., additional, Di Giammarco, G., additional, Canosa, C., additional, Foschi, M., additional, Liberti, G., additional, Bedir, M., additional, Marinelli, D., additional, Masuyama, S., additional, Rabozzi, R., additional, Vijayan, S., additional, Miller, H., additional, Muthusamy, R., additional, Smith, S., additional, Gargani, L., additional, Pang, P., additional, Davis, E., additional, Schumacher, A., additional, Sicari, R., additional, Picano, E., additional, Chmiel, A., additional, Mizia, M., additional, Haberka, M., additional, Gieszczyk, K., additional, Sikora - Puz, A., additional, Lasota, B., additional, Trojnarska, O., additional, Grajek, S., additional, Gasior, Z., additional, Koumoulidis, A., additional, Vlasseros, I., additional, Tousoulis, D., additional, Katsi, V., additional, Avgeropoulou, A., additional, Divani, M., additional, Stefanadis, C., additional, and Kallikazaros, I., additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results